- Home
- GEG vs BTMD Comparison
GEG vs BTMD Comparison
Compare GEG & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GEG | BTMD |
|---|---|---|
| Founded | 1994 | 2012 |
| Country | United States | United States |
| Employees | 50 | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.7M | 64.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GEG | BTMD |
|---|---|---|
| Price | $2.05 | $2.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.83 |
| AVG Volume (30 Days) | 10.1K | ★ 296.5K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ N/A | $3.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.80 | $1.27 |
| 52 Week High | $3.51 | $4.75 |
Technical Indicators
Market Signals| Indicator | GEG | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.36 | 72.08 |
| Support Level | $2.02 | $2.02 |
| Resistance Level | $2.19 | $2.37 |
| Average True Range (ATR) | 0.05 | 0.14 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 28.57 | 92.70 |
Price Performance
Historical ComparisonAbout GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.